Alatrofloxacin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Alatrofloxacin
Alatrofloxacin.svg
Systematic (IUPAC) name
7-[(1R,5S)-6-{[(2S)-1-{[(2S)-2-Aminopropanoyl]amino}-1-oxopropan-2-yl]amino}-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid
Clinical data
AHFS/Drugs.com Micromedex Detailed Consumer Information
MedlinePlus a605016
Pregnancy cat.
Legal status
  • Withdrawn
Routes Intravenous
Pharmacokinetic data
Bioavailability N/A
Protein binding 76% (trovafloxacin)
Metabolism Quickly hydrolyzed to trovafloxacin
Half-life 9 to 12 hours (trovafloxacin)
Excretion Fecal and renal (trovafloxacin)
Identifiers
CAS number 157182-32-6 N 157605-25-9
ATC code None
ChemSpider 21243647 N
UNII 7QVV6I50DT YesY
ChEMBL CHEMBL1201197 N
Chemical data
Formula C26H25F3N6O5 
Mol. mass 558.509 g/mol
 N (what is this?)  (verify)

Alatrofloxacin (Trovan IV) is a fluoroquinolone antibiotic developed by Pfizer, delivered as a mesylate salt.[1]


Trovafloxacin and alatrofloxacin were both withdrawn from the U.S. market in 2001.

See also[edit]

References[edit]

  1. ^ http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020760a_chemr.pdf.